earli read result alert
report solid morn beat top-lin
penni beat bottom first quarter sale
organ came consensu broad-bas out-performance
notabl cardiovascular neuromodul
bottom line ep came street
strong top-lin also benefit better gm lower tax
full year boston rais report sale guidanc
also rais top organ growth rang
bottom-lin manag also rais ep outlook
vs street
boston rais top bottom-lin guidanc organ
manag rais sale guidanc
organ organ includ benefit
symeti vs previous ep guidanc also rais
growth per share vs current street expect guidanc
point toward sale report
organ street ep
street
new rhythm neuro segment post strong first quarter
three combin legaci segment ep neuro beat
sale came street low doubl digit
sale led launch reson continu doubl digit growth
emblem neuromodul sale came
street driven intern strength recent launch
wavewrit vercis final electrophysiolog sale
came strong perform rhythmia hdx particularli
europ japan
intervent cardiolog peripher vascular also
strong intervent cardiolog sale organ benefit
continu strength watchman upsid acur double-digit growth
complex pci peripher benefit continu de adopt europ
atherectomi boston urolog busi also good quarter
continu strength lithovu men
endoscopi busi grew came
 gross margin strength help drive ep beat gross
margin quarter street sg expens
came in-lin street expect
lower-than-expect tax rate vs help ep beat
ahead street
page analyst certif import disclosur
 morgan seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report singl
factor make invest decis
analyst certif research analyst denot ac cover report certifi multipl research
analyst primarili respons report research analyst denot ac cover within document
individu certifi respect secur issuer research analyst cover research view
express report accur reflect person view subject secur issuer part
research analyst compens directli indirectli relat specif recommend view
express research analyst report korea-bas research analyst list front cover also certifi per
kofia requir analysi made good faith view reflect opinion without undu influenc
market maker/ liquid provid morgan secur plc and/or affili market maker and/or liquid provid
secur issu boston scientif corpor
lead co-manag morgan act lead co-manag public offer equiti and/or debt secur boston
scientif corpor within past month
client morgan current within past month follow entiti client boston scientif corpor
client/invest bank morgan current within past month follow entiti invest
client/non-invest bank securities-rel morgan current within past month follow
entiti client servic provid non-investment-bank securities-rel boston scientif corpor
client/non-securities-rel morgan current within past month follow entiti client
servic provid non-securities-rel boston scientif corpor
invest bank past month morgan receiv past month compens invest bank servic
boston scientif corpor
invest bank next month morgan expect receiv intend seek compens invest bank
servic next three month boston scientif corpor
non-invest bank compens morgan receiv compens past month product servic
invest bank boston scientif corpor
signific financi interest morgan own posit million usd debt secur boston
company-specif disclosur import disclosur includ price chart credit opinion histori tabl avail
compendium report morgancov compani visit http //www jpmm com/research/disclosur call
e-mail request morgan strategi technic quantit
research team may screen compani cover morgan import disclosur compani pleas call
email
bloomberg morgan price data adjust stock split dividend
chart show morgan continu coverag stock current analyst may may cover entir
 morgan rate design ow overweight neutral uw underweight nr rate
explan equiti research rate design analyst coverag univers
 morgan use follow rate system overweight next six twelv month expect stock outperform
averag total return stock analyst analyst team coverag univers neutral next six twelv
month expect stock perform line averag total return stock analyst analyst team
coverag univers underweight next six twelv month expect stock under-perform averag total return
stock analyst analyst team coverag univers rate nr morgan remov rate
applic price target stock either lack suffici fundament basi legal regulatori polici
reason previou rate applic price target longer reli upon nr design
recommend rate asia ex-australia ex-india small- mid-cap equiti research stock expect
total return compar expect total return benchmark countri market index analyst coverag univers
appear import disclosur section report certifi analyst coverag univers found
